Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells

Cancer Science

Volumn 103, Issue 2, 2012, Pages 221-227

  Furuta, Kazuyuki ^a,b   Arao, Tokuzo ^a   Sakai, Kazuko ^a   Kimura, Hideharu ^a   Nagai, Tomoyuki ^a   Tamura, Daisuke ^a   Aomatsu, Keiichi ^a   Kudo, Kanae ^a   Kaneda, Hiroyasu ^a   Fujita, Yoshihiko ^a   Matsumoto, Kazuko ^a   Yamada, Yasuhide ^c   Yanagihara, Kazuyoshi ^d   Sekijima, Masaru ^b   Nishio, Kazuto ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; CADHERIN 13 PROTEIN; CATENIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; PROTEIN KINASE; PROTEIN KINASE A CATALYTIC SUBUNIT BETA PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EXON; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA SPLICING; STOMACH CANCER;

ALTERNATIVE SPLICING; BASE SEQUENCE; CADHERINS; CATENINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIC AMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNITS; EXONS; GENE AMPLIFICATION; GENE DOSAGE; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; PROTEIN KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS;

EID: 84856493407     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02132.x     Document Type: Article

References (17)

1. Xi L, Feber A, Gupta V et al. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res 2008; 36: 6535-47.
2. Cheung HC, Baggerly KA, Tsavachidis S et al. Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. BMC Genomics 2008; 9: 216.
3. Soreq L, Gilboa-Geffen A, Berrih-Aknin S et al. Identifying alternative hyper-splicing signatures in MG-thymoma by exon arrays. PLoS ONE 2008; 3: e2392.
4. Gardina PJ, Clark TA, Shimada B et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006; 7: 325.
5. Shinawi M, Cheung SW. The array CGH and its clinical applications. Drug Discov Today 2008; 13: 760-70.
6. Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, Montuenga LM. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 2007; 8: 349-57.
7. Arao T, Fukumoto H, Takeda M, Tamura T, Saijo N, Nishio K. Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474. Cancer Res 2004; 64: 9101-4.
8. Kaneda H, Arao T, Tanaka K et al. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res 2010; 70: 2053-63.
9. Gerits N, Kostenko S, Shiryaev A, Johannessen M, Moens U. Relations between the mitogen-activated protein kinase and the cAMP-dependent protein kinase pathways: comradeship and hostility. Cell Signal 2008; 20: 1592-607.
10. Ørstavik S, Reinton N, Frengen E, Langeland BT, Jahnsen T, Skålhegg BS. Identification of novel splice variants of the human catalytic subunit Cbeta of cAMP-dependent protein kinase. Eur J Biochem 2001; 268: 5066-73.
11. Murray AJ. Pharmacological PKA inhibition: all may not be what it seems. Sci Signal 2008; 1: re4.
12. Higuchi H, Yamashita T, Yoshikawa H, Tohyama M. PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts. EMBO J 2003; 22: 1790-800.
13. Brooks-Wilson AR, Kaurah P, Suriano G et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41: 508-17.
14. MacConaill LE, Campbell CD, Kehoe SM et al. Profiling critical cancer gene mutations in clinical tumor samples. PLoS ONE 2009; 4: e7887.
15. Takeda M, Arao T, Yokote H et al. AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor. Clin Cancer Res 2007; 13: 3051-7.
16. Kim JS, Han J, Shim YM, Park J, Kim DH. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary non-small cell lung carcinoma. Cancer 2005; 104: 1825-33.
17. Cowan-Jacob SW, Möbitz H, Fabbro D. Structural biology contributions to tyrosine kinase drug discovery. Curr Opin Cell Biol 2009; 21: 280-7.